申联生物上周获融资净买入1468.38万元，居两市第491位

Core Viewpoint - Shanyuan Biological has shown significant financing activity with a net buy of 14.68 million yuan last week, indicating investor interest and potential growth in the biopharmaceutical sector [1] Financing Activity - Shanyuan Biological recorded a total financing buy of 57.79 million yuan and repayment of 43.11 million yuan last week [1] - The company ranked 491st in terms of net financing buy across the market [1] Capital Flow - Over the past 5 days, the main capital inflow into Shanyuan Biological was 71.45 million yuan, with a price increase of 13.32% [1] - In the last 10 days, the capital inflow was 71.48 million yuan, reflecting a price increase of 10.0% [1] Company Profile - Shanyuan Biological Pharmaceutical (Shanghai) Co., Ltd. was established in 2001 and is located in Shanghai, primarily engaged in the pharmaceutical manufacturing industry [1] - The company has a registered capital of 410.644 million yuan and a paid-in capital of 316.897548 million yuan [1] - The legal representative of the company is Nie Dongsheng [1] Investment and Intellectual Property - Shanyuan Biological has invested in 7 external companies and participated in 1,602 bidding projects [1] - The company holds 31 trademark registrations and 143 patents, along with 54 administrative licenses [1]